コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 eplicated findings in an independent sample (replication study).
2 with the risk of clinical CAD in this large replication study.
3 all 12 SNPs were confirmed in an independent replication study.
4 consideration to whether it is a de novo or replication study.
5 risons between NC1 and the autism group as a replication study.
6 en (mean [SD] age, 25.4 [6.0] months) in the replication study.
7 hese associations were also significant in a replication study.
8 ucoma patients in a second sample used for a replication study.
9 a meta-analysis with a published GWAS and a replication study.
10 spectively) but not to cephalosporins in the replication study.
11 ant predictor of the P-value in a subsequent replication study.
12 hese experiments will then be published in a Replication Study.
13 identify SNPs that can be pursued in future replication studies.
14 covery studies and 32 277 individuals from 6 replication studies.
15 y identified, and 5 SNPs were later found in replication studies.
16 Two additional cohorts were used for replication studies.
17 the initial GWAS were not associated in the replication studies.
18 tiology of NHL, and should be prioritized in replication studies.
19 that variant and facilitate the planning of replication studies.
20 esting additional variants is commonplace in replication studies.
21 novel risk loci that require confirmation by replication studies.
22 ary in the absence of converging evidence or replication studies.
23 peline as open-source software to facilitate replication studies.
24 irus (CCMV) is a widely used model for virus replication studies.
25 ocumentation of indications would facilitate replication studies.
26 t their institution valued new research over replication studies.
27 The UK Biobank dataset was used for the replication studies.
28 fect estimates from the GIANT consortium and replication studies.
29 showed evidence of trans-association in two replication studies.
30 DCYAP1R1 were genotyped in our study and six replication studies.
31 diseases, often with inconsistent results in replication studies.
32 mbined meta-analysis of all 22 discovery and replication studies.
33 ditors publishing in their own journals, and replication studies.
34 associated overall and in 3 of 5 individual replication studies.
35 (cases) and 3,182 controls), an independent replication study (1,440 cases and 1,316 controls) and a
36 e each type's heterogeneity from 70 multilab replication studies, 11 prospective meta-analyses of stu
37 iginal study: 44 total (20 PTSD); conceptual replication study: 40 total (20 PTSD)) underwent threat
39 N22 (discovery-study allelic P=6.6 x 10(-4); replication-study allelic P=5.6 x 10(-8)), which encodes
43 sis for the design and interpretation of GWA replication studies and point to the importance of a cle
44 egrative summary, we review various types of replication studies and then discuss the most commonly v
46 such two-stage data is to view stage 2 as a replication study and focus on findings that reach stati
47 rried out a genome-wide association scan and replication study and found an association between SLE a
50 t GTF2I by heterogeneity mapping followed by replication studies, and pinpointed a possible causal va
51 from China and 2 from the United States) for replication studies, and we identified heterozygous MGA
52 he presence of real effects in a low-powered replication study, and instances of such association inc
53 lation controls; performed follow-up genetic replication studies; and, conducted in silico and in vit
54 al white populations were used for follow-up replication studies: another independent cohort of CAD-
68 only tentative evidence of association, and replication studies are required to establish their vali
69 ty to diabetic retinopathy; however, further replication studies are required to validate these assoc
75 atio of sample sizes between the initial and replication studies, but not on the underlying effect si
81 ents and 866 healthy controls, followed by a replication study comprising 658 patients with invasive
86 alysis of primary results was performed with replication studies containing 12 174 heavy and 11 290 l
89 , we report the results of a discovery and a replication study, each involving a double-blind, placeb
91 tients and 400 controls from the U.S. and in replication studies for 308 POAG patients and 178 contro
92 covalently bonded, and carried out in vitro replication studies for the lesion-bearing substrate wit
94 op prediction intervals for the P-value in a replication study given the P-value observed in an initi
98 e association studies (GWAS) and large-scale replication studies have identified common variants in 7
101 ificant results in both the original and the replication study have been interpreted as a 'replicatio
107 in the Pune Maternal Nutrition Study (PMNS), replication studies in 3418 individuals from other India
108 which was followed by in silico and de novo replication studies in 37,691 and 17,642 additional east
112 PMBB with WES linked to EHR phenotypes, with replication studies in BioVU, UK Biobank, MyCode, and DC
116 -wide genotyping of the European cohorts and replication studies in the Japanese cohort identified co
117 thnically matched controls, and we performed replication studies in two independent European cohorts.
121 432,028 controls of European ancestry and a replication study in 3989 cases and 226,643 controls pro
122 subsequent transmission disequilibrium test replication study in an independent cohort confirmed the
125 69 individuals to 293,723 individuals, and a replication study in an independent sample of 111,349 in
129 osis household contact study in France and a replication study in families from South Africa to confi
133 sychedelic drug research that merit rigorous replication studies include 3,4-Methylenedioxymethamphet
134 of lipid levels in 8344 subjects followed by replication studies including 14 739 additional individu
135 hypertension in 11 816 subjects followed by replication studies including 69 146 additional individu
136 e rankings were followed up in a three-stage replication study including 4,064 cases and 4,685 contro
137 l associations that can be pursued in future replication studies, including an intergenic SNP, rs4761
138 ed progress, including a lack of large-scale replication studies, inconsistencies in defining valid t
141 ical evidence from two large-scale multisite replication studies indicating that covariate shift can
145 s further delineated in: (1) a pooling-based replication study involving an additional 500 AN patient
146 orts (n = 13,813) followed by two additional replication studies (n = 2,267) including approximately
149 t a genome-wide association (n = 17,967) and replication study (n = 13,615) to identify genetic loci
151 of previous studies, n = 450; pre-registered replication study, n = 807), we investigated how depress
154 from 11 studies and followed up 6 SNPs in 3 replication studies of 2,198 cases and 4,918 controls.
158 ction: Genetics and Environment, followed by replication studies of prioritized single nucleotide pol
159 whose bypass adheres to the "A-rule." Recent replication studies of the oxidized abasic lesion, 2-deo
160 ce analysis of HLA-DRB3 exon 2 in a targeted replication study of 281 informative T1D family members
161 lipoprotein(a) level measurements, and in a replication study of 379 patients with echocardiography-
164 a trans-ancestry genome-wide association and replication study of blood pressure phenotypes among up
168 asthma risk loci by performing an extensive replication study of the results from the EVE Consortium
171 enes on metabolic outcomes; however, further replication studies on large samples are needed to confi
172 further genotyped this SNP in two subsequent replication studies (one with 3,750 women and the other
173 e association study (P < 5 x 10(-8)) and the replication studies (P < .05), including a missense vari
177 indings from genome-wide association through replication studies, preferably using multi-omic dataset
178 scoping review to identify English language replication studies published between 2018 and 2019 in e
179 Replication experiments were completed and Replication Studies reporting the results were submitted
187 he three novel SNPs were followed-up in nine replication studies (Stage 2; N = 11 995), with rs905938
189 ss to raw data and protocols, the conduct of replication studies, systematic integration of evidence
192 e body of structural, biochemical, and virus replication studies that identify several inhibitors of
194 lly genotyped in an independent family-based replication study that, after quality control, consisted
196 s) of the four GWAS discovery scans and four replication studies, the 3p24.1 locus (rs6773363; MAF =
197 four original GWAS discovery scans and three replication studies, the 3q13.33 locus (rs9831894; minor
203 ing both reproducible research standards and replication studies to evaluate the fragility of study f
204 erestimation of the genetic effect may cause replication studies to fail because the necessary sample
205 e parafovea, emphasizing the contribution of replication studies to substantiate our knowledge about
208 formed genome-wide association Discovery and Replication Studies using cohorts of 2131 patients with
213 wide association analysis and an independent replication study using a total of 1131 bladder cancer c
214 gammaRIIA and FcgammaRIIIA in a case-control replication study, using allele-specific polymerase chai
218 nvestigations, a genome-wide association and replication study was conducted in two smoker cohorts to
222 corded whether a registered protocol for the replication study was used, whether there was contact be
237 structural region are likely to affect viral replication, studies were performed to evaluate the effe
239 chology we illustrate that many original and replication studies with 'null results' are in fact inco
240 events, facilitating larger-scale and higher-replication studies with an expanded number of species.
241 TES effect, we performed detailed retroviral replication studies with an NSI/R5 (B-92BR021) and SI/X4
242 evated risk of lung cancer from the combined replication studies with an OR of 1.15 (95% CI, 1.04-1.5
244 authors now present a randomized controlled replication study with baseline, postintervention, and 3
245 iral life cycle, we carried out a systematic replication study with entire genomes of human papilloma
246 xposure in conjunction with a-priori planned replication studies would reduce the number of false pos